Is MAIA Biotechnology, Inc. (MAIA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 16.8% / 30% | 0.1% / 30% | N/A | ✓ HALAL |
| DJIM | 0.0% / 33% | 16.8% / 33% | 0.1% / 33% | N/A | ✓ HALAL |
| MSCI | 0.0% / 33% | 94.5% / 33% | 0.8% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.0% / 33% | 16.8% / 33% | 0.1% / 33% | N/A | ✓ HALAL |
| FTSE | 0.0% / 33% | 94.5% / 33% | 0.8% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -745.2% | |
| Return on Assets (ROA) | -152.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$16M |
| Free Cash Flow | -$16M |
| Current Ratio | 1.7 |
| Total Assets | $10M |
Price & Trading
| Last Close | $1.38 |
| 50-Day MA | $1.91 |
| 200-Day MA | $1.60 |
| Avg Volume | 1.1M |
| Beta | -0.0 |
|
52-Week Range
$0.87
| |
About MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is MAIA Biotechnology, Inc. (MAIA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), MAIA Biotechnology, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is MAIA Biotechnology, Inc.'s debt ratio?
MAIA Biotechnology, Inc.'s debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.0%.
What are MAIA Biotechnology, Inc.'s key financial metrics?
MAIA Biotechnology, Inc. has a market capitalization of $79M. Return on equity stands at -745.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.